ArticleHeart rhythm O22026
Electrophysiological and electrocardiographic characteristics of ventricular arrhythmias successfully treated by coronary venous ethanol ablation.
Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coronary venous ethanol ablation (CVEA) is increasingly used for the treatment of ventricular arrhythmias (VAs). Objective: This study aimed to characterize the features of VAs eliminated by CVEA. Methods: Consecutive patients who underwent CVEA were prospectively enrolled and classified as acute success or failure groups. Targeted veins were categorized as the first septal vein (S1), left ventricular annular vein (LVA), or anterior interventricular vein (AIV). Results: 42 patients (mean age 52.5 ± 14.3 years; 42.9% female) underwent CVEA; 29 (69.0%) achieved acute success. Ethanol was delivered via S1 in 16 patients, LVA in 8, and AIV in 5. In success cases, S1- and LVA-eliminated VAs exhibited similar right bundle branch block-like morphologies, whereas AIV-related VAs showed a left bundle branch block pattern with QS in leads V1-V2 and late precordial R-wave transition. During ethanol infusion, a transient "irritative" response in VA burden occurred in 44.8% of patients and was more frequently observed in successful cases. Complications were limited to transient bundle branch block in 4 of 42 (9.5%) and transient ST-T changes in 1 of 42 (2.4%), which resolved spontaneously after pausing/terminating ethanol infusion as needed. During follow-up, 4 patients experienced VA recurrences. One underwent repeat CVEA at the same target vein, and 3 were successfully managed with drug therapy. Conclusion: Successful CVEA from S1 and LVA yield similar electrocardiographic morphologies, whereas AIV-related VAs were characterized by QS in V1-V2 with late precordial transition. An irritative response during ethanol infusion may indicate effective ablation, and ethanol delivery from S1 or LVA may induce transient bundle branch block.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.